• 
  F. Derquin, A. Floquet, A.C. Hardy-Bessard, J. Edeline, J.P. Lotz, et al.. Need for risk-adapted therapy for malignant ovarian germ cell tumors: A large multicenter analysis of germ cell tumors' patients from French TMRG network. Gynecologic Oncology, Elsevier, 2020, 158 (3), pp.666-672. ⟨10.1016/j.ygyno.2020.06.491⟩. ⟨hal-02909552⟩
• 
  Julie Lecarpentier, Catherine Noguès, Emmanuelle Mouret-Fourme, Dominique Stoppa-Lyonnet, Christine Lasset, et al.. Variation in breast cancer risk with mutation position smoking alcohol and chest X-ray history in the French National BRCA1/2 carrier cohort (GENEPSO). Breast Cancer Research and Treatment, Springer Verlag, 2011, 130 (3), pp.927-938. ⟨10.1007/s10549-011-1655-3⟩. ⟨hal-00698006⟩
• 
  L. Julien, J. Genet, N. Leymarie, J.-F. Honart, F. Rimareix, et al.. Comparaison des résultats de reconstruction mammaire immédiate par prothèse avec et sans radiothérapie. Annales de Chirurgie Plastique Esthétique, Elsevier Masson, 2020, 65, pp.181 - 197. ⟨10.1016/j.anplas.2019.12.002⟩. ⟨hal-03490268⟩
• 
  Guillaume Janoray, Yoann Pointreau, Marc Alfonsi, Christian Sire, Lionel Geoffrois, et al.. Induction chemotherapy followed by cisplatin or cetuximab concomitant to radiotherapy for laryngeal/hypopharyngeal cancer: Long-term results of the TREMPLIN randomised GORTEC trial. European Journal of Cancer, Elsevier, 2020, 133, pp.86 - 93. ⟨10.1016/j.ejca.2020.04.009⟩. ⟨hal-03490774⟩
• 
  Jérôme Durand-Labrunie, Anne-Sophie Baumann, Ahmet Ayav, Valérie Laurent, Emmanuel Boleslawski, et al.. Curative Irradiation Treatment of Hepatocellular Carcinoma: A Multicenter Phase 2 Trial. International Journal of Radiation Oncology, Biology, Physics, Elsevier, 2020, 107, pp.116 - 125. ⟨10.1016/j.ijrobp.2019.12.004⟩. ⟨hal-03490661⟩
• 
  Christian Carrie, Nicolas Magné, Patricia Burban-Provost, Paul Sargos, Igor Latorzeff, et al.. Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial. Lancet Oncology, Elsevier, 2019, 20, pp.1740 - 1749. ⟨10.1016/S1470-2045(19)30486-3⟩. ⟨hal-03489049⟩
• 
  P. Gougis, M. Carton, C. Tchokothe, M. Campone, F. Dalenc, et al.. CinéBreast-factors influencing the time to first metastatic recurrence in breast cancer: Analysis of real-life data from the French ESME MBC database. The Breast, 2020, 49, pp.17-24. ⟨10.1016/j.breast.2019.10.004⟩. ⟨hal-02888468⟩
• 
  Béatrice Bouvard, Cyrille B. Confavreux, Karine Briot, Jacques Bonneterre, Catherine Cormier, et al.. Recommandations françaises de stratégies thérapeutiques pour la prévention et le traitement de l’ostéoporose induite par les traitements adjuvants du cancer du sein. Revue du Rhumatisme, Elsevier, 2019, 86, pp.426 - 437. ⟨10.1016/j.rhum.2019.05.005⟩. ⟨hal-03488970⟩
• 
  Christophe Borg, Georges Mantion, Frank Boudghène, Françoise Mornex, François Ghiringhelli, et al.. Efficacy and Safety of Two Neoadjuvant Strategies With Bevacizumab in MRI-Defined Locally Advanced T3 Resectable Rectal Cancer: Final Results of a Randomized, Noncomparative Phase 2 INOVA Study. Clinical Colorectal Cancer, Elsevier, 2019, 18, pp.200 - 208.e1. ⟨10.1016/j.clcc.2019.04.006⟩. ⟨hal-03487688⟩
• 
  Yohan Fayet, Christine Chevreau, Gauthier Decanter, Cécile Dalban, Pierre Méeus, et al.. No Geographical Inequalities in Survival for Sarcoma Patients in France: A Reference Networks' Outcome?. Cancers, MDPI, 2022, 14 (11), pp.2620. ⟨10.3390/cancers14112620⟩. ⟨hal-03718397⟩
• 
  Sophie Frank, Matthieu Carton, Coraline Dubot, Mario Campone, Barbara Pistilli, et al.. Impact of age at diagnosis of metastatic breast cancer on overall survival in the real-life ESME metastatic breast cancer cohort. Breast, Elsevier, 2020, 52, pp.50-57. ⟨10.1016/j.breast.2020.04.009⟩. ⟨hal-02888009v2⟩
• 
  Cécile Charles, Aurélie Bardet, Alicia Larive, Philip Gorwood, Nicolas Ramoz, et al.. Characterization of Depressive Symptoms Trajectories After Breast Cancer Diagnosis in Women in France. JAMA Network Open, American Medical Association, 2022, 5 (4), pp.e225118. ⟨10.1001/jamanetworkopen.2022.5118⟩. ⟨inserm-03650391⟩
• 
  Fabien Moinard-Butot, Caroline Saint-Martin, Carole Pflumio, Matthieu Carton, William Jacot, et al.. Efficacy of trastuzumab emtansine (T-DM1) and lapatinib after dual HER2 inhibition with trastuzumab and pertuzumab in patient with metastatic breast cancer: Retrospective data from a French multicenter real-life cohort. Breast, Elsevier, 2022, 63, pp.54-60. ⟨10.1016/j.breast.2022.03.004⟩. ⟨hal-03647242⟩
• 
  B Teste, P Rouanet, J-J Tuech, A Valverde, B Lelong, et al.. Early and late morbidity of local excision after chemoradiotherapy for rectal cancer. BJS Open, Oxford University Press, 2021, 5 (3), pp.zrab043. ⟨10.1093/bjsopen/zrab043⟩. ⟨hal-03637680⟩
• 
  Nadia Oubaya, Pierre Soubeyran, Nicoleta Reinald, Marianne Fonck, Mylene Allain, et al.. Prognostic Value of Routinely Measured Inflammatory Biomarkers in Older Cancer Patients: Pooled Analysis of Three Cohorts. Cancers, MDPI, 2021, 13 (24), pp.6154. ⟨10.3390/cancers13246154⟩. ⟨hal-03540655⟩
• 
  David Pasquier, Amélie Darlix, Guillaume Louvel, Julien Fraisse, William Jacot, et al.. Treatment and outcomes in patients with central nervous system metastases from breast cancer in the real-life ESME MBC cohort. European Journal of Cancer, Elsevier, 2020, 125, pp.22-30. ⟨10.1016/j.ejca.2019.11.001⟩. ⟨hal-02887998⟩
• 
  Carole Pflumio, Idriss Troussier, Xu Shan Sun, Julia Salleron, Claire Petit, et al.. Unilateral or bilateral irradiation in cervical lymph node metastases of unknown primary? A retrospective cohort study. European Journal of Cancer, Elsevier, 2019, 111, pp.69 - 81. ⟨10.1016/j.ejca.2019.01.004⟩. ⟨hal-03486172⟩
• 
  Mylene Annonay, Lisa Gauquelin, Romain Geiss, Mony Ung, Laurence Cristol-Dalstein, et al.. Treatment and outcomes of older versus younger women with HER2-positive metastatic breast cancer in the real-world national ESME database. Breast, Elsevier, 2021, 60, pp.138-146. ⟨10.1016/j.breast.2021.09.011⟩. ⟨hal-03468488⟩
• 
  Benjamin Cuer, Thierry Conroy, Beata Juzyna, Sophie Gourgou, Caroline Mollevi, et al.. Joint modelling with competing risks of dropout for longitudinal analysis of health-related quality of life in cancer clinical trials. Quality of Life Research, Springer Verlag, In press, ⟨10.1007/s11136-021-03040-8⟩. ⟨hal-03467977⟩
• 
  Gilles Houvenaeghel, Monique Cohen, Pédro Raro, Jérémy de Troyer, Pierre Gimbergues, et al.. Sentinel node involvement with or without completion axillary lymph node dissection: treatment and pathologic results of randomized SERC trial. npj Breast Cancer, Nature, 2021, 7 (1), pp.133. ⟨10.1038/s41523-021-00336-3⟩. ⟨hal-03406273⟩

88

178